Nephros Strengthens Commercialization Team with Addition of Marketing...( NEW YORK April 21 /- Nephros Inc....),Health

NEW YORK, April 21 /PRNewswire-FirstCall/ -- Nephros, Inc. (AMEX: NEP), a medical device company specializing in the treatment of end-stage renal disease, today announced that it has named Joleen C. Turner to be Vice President of Marketing and Business Development, effective today.

In this role, Ms. Turner, an experienced international marketing executive, will lead the development of Nephros's marketing strategy, identifying new markets and channels, and applying the creative use of new media communications.

"I am pleased to welcome Joleen to the Nephros team," Nephros CEO Norman J. Barta said. "Joleen's experience and expertise solidify the company's commercialization resources as Nephros pursues its goal of aggressively expanding product sales."

Ms. Turner's appointment comes as Nephros plans the launch of its OLpur(TM) H2H(TM) Hemodiafiltration Module and OLpur(TM) MD 220 Hemodiafilter products in the United States, subject to receiving the requisite regulatory approvals.

Ms. Turner has 20 years of international experience in strategic marketing, product development and product commercialization with high technology, professional service and life-science corporations. Since June 2006, she has been an independent consultant working with companies such as Boehringer Ingelheim, Pfizer, and Pepsico. She recently led the marketing and packaging launch of a leading respiratory combination drug with revenues now exceeding US $1 billion.

Previously Ms. Turner held the position of Director, Strategic Programs, for Aris Global, a leader in life-science safety and regulatory technology solutions, where her strategic marketing initiatives contributed to the company's record growth and success in the regulatory an
'/>"/>